Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALEMBIC

  • FDA Approval
  • Aug. 05, 2025, 08:53 UTC
  • 62
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Comment Full text

SUN PHARM

  • FDA Approval
  • Aug. 05, 2025, 08:53 UTC
  • 59
  • 0 comments

FDA approve MINOCYCLINE HYDROCHLORIDE

Comment Full text

SANOFI AVENTIS US

  • FDA Approval
  • Aug. 04, 2025, 18:04 UTC
  • 69
  • 0 comments

FDA approve IRBESARTAN

Comment Full text

SANOFI AVENTIS US

  • FDA Approval
  • Aug. 04, 2025, 09:02 UTC
  • 48
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; IRBESARTAN

Comment Full text

SANOFI AVENTIS US

  • FDA Approval
  • Aug. 04, 2025, 09:02 UTC
  • 59
  • 0 comments

FDA approve IRBESARTAN

Comment Full text

HOSPIRA

  • FDA Approval
  • July 31, 2025, 22:05 UTC
  • 78
  • 0 comments

FDA approve ATROPINE SULFATE

Comment Full text

ROSEMONT PHARMACEUTICALS INC

  • FDA Approval
  • July 31, 2025, 21:34 UTC
  • 61
  • 0 comments

FDA approve METHOCARBAMOL

Comment Full text

ESJAY PHARMA

  • FDA Approval
  • July 31, 2025, 08:51 UTC
  • 56
  • 0 comments

FDA approve ATENOLOL

Comment Full text

CHARTWELL RX

  • FDA Approval
  • July 31, 2025, 08:51 UTC
  • 62
  • 0 comments

FDA approve QUINIDINE SULFATE

Comment Full text

ESJAY PHARMA

  • FDA Approval
  • July 31, 2025, 08:51 UTC
  • 61
  • 0 comments

FDA approve ATENOLOL

Comment Full text
  • Previous
  • 114
  • 115
  • 116
  • 117
  • 118
  • Next

Search

News categories

  • Technical Exchange News(12220)
  • Event(6113)
  • SEC News(262591)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(153957)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin